NVG-291: A Breakthrough for Paralysis
from Cleveland News Today | 2 Min News | The Daily News Now!
NVG-291: A Game-Changing Drug for Paralysis - A groundbreaking drug, NVG-291, developed at Case Westerns biotech incubator, is restoring movement to individuals paralyzed from spinal cord injuries. Stayce Westington, an emergency room nurk who became paralyzed, is one of the success stories. The drug targets scar tissue that blocks nerve regrowth, with promising results in animal trials and human phase two trials. Researchers aim to expand its use to stroke victims, brain injuries, Parkinsons, Alzheimers, and ALS, offering hope for millions to regain normal lives. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/1aa782a948933b8d
Embed this episode
No transcript yet.